Pfizer/Pharmacia deal
This article was originally published in The Rose Sheet
Executive Summary
Pharmaceutical firm to acquire Rogaine hair regrowth business and other OTC treatment products such as the Nicorette smoking cessation brand as part of the company's Rx-driven acquisition of Pharmacia. With $732 mil. in revenue in 2001, Pharmacia's OTC business will be folded into Pfizers significantly larger consumer health operations, Pfizer Chairman and CEO Hank McKinnel said during a 1July 15 merger briefing. Pfizer Consumer Healthcare, with sales of $2.45 bil. in 2001, includes Listerine mouthwash and Benadryl allergy remedies. Pfizer planning to acquire Pharmacia in a $60 bil. stock-for-stock transaction...
You may also be interested in...
Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations
US FDA oncology officials are concerned that the entities sponsors are consulting in developing and implementing clinical trial diversity plans are not sufficiently diverse themselves and do not represent patients in underserved communities.
Israeli Company Lands De Novo Clearance For Digital Bone Marrow Application
The US FDA has cleared a novel software application to enhance the analysis of bone marrow smears. Using the AI-powered tool, hematopathologists may be able to better diagnose various blood and marrow diseases.
Marinomed Takes Virus-Blocking Device Into Allergy And Dry Eye Categories
Virus-blocking compound Carragelose, out-licensed to major consumer health players such as Perrigo and Reckitt for use in OTC respiratory nasal sprays, is being adapted for use in the dry eye and allergy categories.